Prognostic value of c-erbB2 expression in breast cancer.
about
Young age: an independent risk factor for disease-free survival in women with operable breast cancerPrognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.Circadian disruption and breast cancer: an epigenetic link?Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancerMinireview: Tipping the balance: ligand-independent activation of steroid receptors.Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts.Risk factors for distant metastasis as a primary site of treatment failure in early-stage breast cancer.Role of steroid hormones and growth factors in breast cancer.Novel pharmacological approaches in the treatment of breast cancer.Targeted therapy in breast cancer: the HER-2/neu gene and protein.A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer.COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterpartsRole of Cyclooxygenase 2 (COX-2) in Prognosis of Breast Cancer.Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate.Latest biopsy approach for suspected metastases in patients with breast cancer.Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor model.Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.
P2860
Q24791855-37B693E7-3678-4FD0-984F-6ED94E55092EQ25257601-A90F759C-9AC4-42DF-871F-E05DB3D4573FQ26798258-FC086504-5205-4810-A0B5-C8F60D70F9CCQ33250094-2D814618-602C-4C43-A569-33628B8161BCQ33631775-78A2C689-3568-4105-B25A-87126997DBABQ33856732-4AFF2C0C-607B-4C3B-A910-C78E1682FD3AQ34774308-A26BD5E3-A73A-4D71-8AD2-149D236F7446Q35023097-855B699F-BA42-4AC3-96D2-E13C53B80223Q35143980-5D809DCC-10F2-4AAA-8C9D-CFF456176430Q35648508-04229D69-E02B-4969-8FDF-610784BC11BCQ36614411-59A07B26-24B1-488E-8D22-6F2178C62B89Q36694470-61F6B226-6DFC-4CC8-9472-148C1301D5F3Q36746712-59C5EF68-05FA-49DE-9E7F-2A7AF3E473D9Q37660357-D4EA0428-2591-499F-91C4-D7CF80240CA5Q37701327-98CA47C5-319B-46FB-AB8B-CA1DBA1135CAQ38154494-72A004A1-D33F-47F5-B792-B198202ED8D9Q38346533-312B629C-0B24-4015-BFDA-613B31A788FDQ44398181-AE29BBCA-02C7-416D-817D-D83C26296137Q53241143-0379EBF4-B095-46F6-BF4E-51F6E69D816D
P2860
Prognostic value of c-erbB2 expression in breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prognostic value of c-erbB2 expression in breast cancer.
@en
Prognostic value of c-erbB2 expression in breast cancer.
@nl
type
label
Prognostic value of c-erbB2 expression in breast cancer.
@en
Prognostic value of c-erbB2 expression in breast cancer.
@nl
prefLabel
Prognostic value of c-erbB2 expression in breast cancer.
@en
Prognostic value of c-erbB2 expression in breast cancer.
@nl
P2093
P2860
P356
P1476
Prognostic value of c-erbB2 expression in breast cancer.
@en
P2093
Shigeru Murakami
Shinichi Tsutsui
Shinji Ohno
Shinya Oda
Yoichi Hachitanda
P2860
P304
P356
10.1002/JSO.10079
P577
2002-04-01T00:00:00Z